The Hemato Oncology Testing Market experienced substantial growth, with a value of USD 7.4 Billion in 2022. It is projected to achieve an impressive revenue of USD 14.03 Billion by 2032, exhibiting a remarkable compound annual growth rate (CAGR) of 9.5% throughout the forecast period. Several key factors contribute to this market's expansion. These include the escalating prevalence of cancer on...